Acquisitions and spinoffs in 2025 surpassed the previous three years, according to a report from Bain & Company.

Johnson & Johnson MedTech (NYSE: JNJ) today announced the full commercial release of its NuVision Nav ultrasound catheter.

From M&A to surgical robotics and user fee negotiations, the medical device industry has a busy year ahead. Check out MedTech ...

Johnson & Johnson today reported fourth quarter results that beat The Street on sales but only matched on earnings.

In this issue: the rise of dark factories in medtech manufacturing, hospital cybersecurity, the sterile processing evolution, ...

The cleanest case study of pharma and diagnostics operating as one strategic engine is Roche. Instead of treating diagnostics ...

Medtech dealmaking rebounded last year, and, in 2026, M&A players are seeking to “outperform the next-best owner” amid softer valuations for assets. | Bain & Company’s new 2026 global M&A report found ...

TD Cowen analysts Mathew Blackman and Drew Ranieri have named their top three medtech picks under their evolving “Bones, Bots ...

Economic realities: Pharma leadership is often conditioned for the "high-risk, high-reward" physics of pipeline assets. MedTech operates on iterative innovation and service-heavy models. Bridging ...

New report analyzes digital demand, growth trends, and competitive dynamics across the healthcare and medical technology sector. Seattle, ...

CEO Ron Nixon highlighted Sanara's 2024 net revenue of $86.7 million, a 33% year-over-year increase, driven by a 39% growth in soft tissue products to $76.1 million and a 6% rise in bone fusion ...

Medtronic made headlines twice this week. First, the company launched its MiniMed 780G insulin pump system integrated with Abbott’s Instinct sensor technology. Then, FDA cleared the company’s Hugo ...